The Veterinary Drugs Market is expected to register a CAGR of 6.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Veterinary Drugs Market report covers analysis by Product (Anti-Infective Drugs, Anti-Inflammatory Drugs, Parasiticides, Others); Route of Administration (Oral Route, Parenteral Route, Topical Route); End User (Veterinary Hospitals, Veterinary Clinics, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Veterinary Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Veterinary Drugs Market Segmentation
Product- Anti-Infective Drugs
- Anti-Inflammatory Drugs
- Parasiticides
- Oral Route
- Parenteral Route
- Topical Route
- Veterinary Hospitals
- Veterinary Clinics
Strategic Insights
Veterinary Drugs Market Growth Drivers- Rising Pet Ownership and Humanization of Pets: One of the main driving factors for the veterinary drugs market is the growing trend of pet ownership across the globe. With pets being increasingly considered part of the family, people are willing to spend on their pets' health and wellbeing. This encompasses not only regular visits to veterinarians and vaccination but also prescription drugs for chronic diseases such as arthritis, diabetes, and heart disease. The trend is also very strong in urban areas due to smaller family sizes and the need for companionship, hence the increase in pet ownership. This humanization of pets calls for owners to spend more on premium healthcare products, thus pushing demand for preventive and therapeutic veterinary drugs.
- Growth in Livestock Production and Food Safety Concerns: As the global population increases, there is a growing need to meet animal-based food products demand such as meat, dairy, and eggs. Increasing livestock production heightens the risk of disease outbreaks possibly affecting both animals and human health. To avoid these risks, veterinary drugs must be used to maintain healthy farm animals to achieve high productivity and meet food safety standards. In addition, government regulations and consumer demand for safe, high-quality food products force livestock producers to follow stringent health protocols, thereby increasing the need for veterinary pharmaceuticals.
- Emerging Zoonotic Diseases and Epidemic Outbreaks: The increasing outbreak of zoonotic diseases highlights the role animal health plays in avoiding global health catastrophes. The sudden onset of such pandemics as avian flu, swine flu, and, most recently, the emergence of COVID-19, attributed to having its origins with zoonotic origin, brings home the requirement for impactful veterinary interventions into animal populations and thus disease prevalence. This recognition has increased.
- Increased Pet Ownership and Humanization of Pets: A key driver of the veterinary drugs market is the international growth in pets. With people regarding pets as the new members of the family, they become more willing to invest in their pets' health and wellbeing. This includes regular check-ups, vaccinations, and drugs for chronic conditions like arthritis, diabetes, and heart diseases. It has been the most prominent in the urban region. With smaller families and loneliness or the urge to have some other creature companion, this demand for pet-owning has risen rapidly. Thus the humanization of pets calls for a spending budget on health products that leads to the demand for preventive as well as curative veterinary drugs.
- Rising Livestock Production and Need for Improved Food Safety: In such a scenario of a rising global population, the requirement to meet the demand for animal-based food products, like meat, dairy, and eggs, would become more pertinent. The surge in livestock production enhances the chance of disease outbreaks and their transmission among animals, eventually affecting humans as well. Veterinary drugs, therefore, assume greater importance in keeping farm animals healthy, increasing productivity, and achieving food safety requirements. In addition, government regulation along with consumers' demand for safe, high-quality food products intensify the need for livestock producers to be strict health protocols which will subsequently increase the demand for veterinary pharmaceuticals.
- New Zoonotic Diseases and Epidemics: The rise in zoonotic diseases—transmissible from animals to humans—has highlighted animal health as being of prime importance in preventing the outbreak of health crises on the global level. Avian influenza, swine flu, and most recently the COVID-19 pandemic, assumed to have zoonotic origins, highlight the need for effective veterinary intervention in controlling animal populations to avert disease. This awareness has been accompanied by a surge in investment in veterinary drugs and vaccines, not just to protect the health of animals but also that of humans as cross-species transmission of disease is prevented.
- Investment in Customized Medicine for Pets: Personalized medicine is a rising trend in veterinary care. Personalized treatments for an individual animal based on genetic profile, lifestyle, and health history will make it possible. Advances in genetic testing and diagnostic tools have opened up possibilities to develop treatment plans for pets tailored to their individual needs, with better efficacy and fewer side effects. It has become more and more attractive to pet owners willing to spend for the best for their animals. Companies that develop customized veterinary drugs and therapies will stand out in the market and help fill the demand for individualized care.
- Partnering with Veterinary Telemedicine Platforms: Telemedicine is revolutionizing the veterinary care delivery model, allowing pet owners and farmers to access veterinary consultations and prescriptions easily. Pharmaceutical companies can seize this opportunity through partnerships with telemedicine services to make veterinary drugs more accessible and easier to distribute and prescribe. Companies can tap into a larger market, make medications more accessible, and foster customer loyalty through streamlined healthcare solutions by integrating their products with telehealth services.
- Emphasis on sustainable and eco-friendly veterinary products: The consideration of sustainability is becoming an essential factor in the veterinary pharmaceuticals market, primarily driven by both consumer demand and regulatory pressure. Eco-friendly veterinary products are of increasing interest to consumers, such as drugs that have a low environmental impact, biodegradable packaging, and sustainable sourcing of ingredients. Companies that develop sustainable products and sustainable supply chain operations can attract environmentally conscious consumers and thereby create a competitive advantage in the market. It also fits with the larger global effort to reduce the environmental footprint of healthcare industries.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Veterinary Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Veterinary Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Veterinary Drugs Market are Rising Pet Ownership and Humanization of Pets, Growth in Livestock Production and Food Safety Concerns, and Emerging Zoonotic Diseases and Epidemic Outbreaks
The key future trends of the market are Increased Pet Ownership and Humanization of Pets, Rising Livestock Production and Need for Improved Food Safety, and New Zoonotic Diseases and Epidemics
The leading players operating in the Veterinary Drugs Market include Zoetis, Boehringer Ingelheim International GmbH, Bayer AG, Eli Lilly and Company, Ceva, Dechra Pharmaceuticals PLC, Intervet Inc. (Merck & Co. Inc.), Virbac, Vetoquinol S.A.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Veterinary Drugs Market - By Product
1.3.2 Veterinary Drugs Market - By Route of Administration
1.3.3 Veterinary Drugs Market - By End User
1.3.4 Veterinary Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VETERINARY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VETERINARY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VETERINARY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. VETERINARY DRUGS - GLOBAL MARKET OVERVIEW
6.2. VETERINARY DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ANTI-INFECTIVE DRUGS
7.3.1. Overview
7.3.2. Anti-Infective Drugs Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY DRUGS
7.4.1. Overview
7.4.2. Anti-Inflammatory Drugs Market Forecast and Analysis
7.5. PARASITICIDES
7.5.1. Overview
7.5.2. Parasiticides Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL ROUTE
8.3.1. Overview
8.3.2. Oral Route Market Forecast and Analysis
8.4. PARENTERAL ROUTE
8.4.1. Overview
8.4.2. Parenteral Route Market Forecast and Analysis
8.5. TOPICAL ROUTE
8.5.1. Overview
8.5.2. Topical Route Market Forecast and Analysis
9. VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. VETERINARY HOSPITALS
9.3.1. Overview
9.3.2. Veterinary Hospitals Market Forecast and Analysis
9.4. VETERINARY CLINICS
9.4.1. Overview
9.4.2. Veterinary Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. VETERINARY DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Veterinary Drugs Market Overview
10.1.2 North America Veterinary Drugs Market Forecasts and Analysis
10.1.3 North America Veterinary Drugs Market Forecasts and Analysis - By Product
10.1.4 North America Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Veterinary Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Veterinary Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Veterinary Drugs Market
10.1.6.1.1 United States Veterinary Drugs Market by Product
10.1.6.1.2 United States Veterinary Drugs Market by Route of Administration
10.1.6.1.3 United States Veterinary Drugs Market by End User
10.1.6.2 Canada Veterinary Drugs Market
10.1.6.2.1 Canada Veterinary Drugs Market by Product
10.1.6.2.2 Canada Veterinary Drugs Market by Route of Administration
10.1.6.2.3 Canada Veterinary Drugs Market by End User
10.1.6.3 Mexico Veterinary Drugs Market
10.1.6.3.1 Mexico Veterinary Drugs Market by Product
10.1.6.3.2 Mexico Veterinary Drugs Market by Route of Administration
10.1.6.3.3 Mexico Veterinary Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Veterinary Drugs Market Overview
10.2.2 Europe Veterinary Drugs Market Forecasts and Analysis
10.2.3 Europe Veterinary Drugs Market Forecasts and Analysis - By Product
10.2.4 Europe Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Veterinary Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Veterinary Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Veterinary Drugs Market
10.2.6.1.1 Germany Veterinary Drugs Market by Product
10.2.6.1.2 Germany Veterinary Drugs Market by Route of Administration
10.2.6.1.3 Germany Veterinary Drugs Market by End User
10.2.6.2 France Veterinary Drugs Market
10.2.6.2.1 France Veterinary Drugs Market by Product
10.2.6.2.2 France Veterinary Drugs Market by Route of Administration
10.2.6.2.3 France Veterinary Drugs Market by End User
10.2.6.3 Italy Veterinary Drugs Market
10.2.6.3.1 Italy Veterinary Drugs Market by Product
10.2.6.3.2 Italy Veterinary Drugs Market by Route of Administration
10.2.6.3.3 Italy Veterinary Drugs Market by End User
10.2.6.4 Spain Veterinary Drugs Market
10.2.6.4.1 Spain Veterinary Drugs Market by Product
10.2.6.4.2 Spain Veterinary Drugs Market by Route of Administration
10.2.6.4.3 Spain Veterinary Drugs Market by End User
10.2.6.5 United Kingdom Veterinary Drugs Market
10.2.6.5.1 United Kingdom Veterinary Drugs Market by Product
10.2.6.5.2 United Kingdom Veterinary Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Veterinary Drugs Market by End User
10.2.6.6 Rest of Europe Veterinary Drugs Market
10.2.6.6.1 Rest of Europe Veterinary Drugs Market by Product
10.2.6.6.2 Rest of Europe Veterinary Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Veterinary Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Veterinary Drugs Market Overview
10.3.2 Asia-Pacific Veterinary Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Veterinary Drugs Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Veterinary Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Veterinary Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Veterinary Drugs Market
10.3.6.1.1 Australia Veterinary Drugs Market by Product
10.3.6.1.2 Australia Veterinary Drugs Market by Route of Administration
10.3.6.1.3 Australia Veterinary Drugs Market by End User
10.3.6.2 China Veterinary Drugs Market
10.3.6.2.1 China Veterinary Drugs Market by Product
10.3.6.2.2 China Veterinary Drugs Market by Route of Administration
10.3.6.2.3 China Veterinary Drugs Market by End User
10.3.6.3 India Veterinary Drugs Market
10.3.6.3.1 India Veterinary Drugs Market by Product
10.3.6.3.2 India Veterinary Drugs Market by Route of Administration
10.3.6.3.3 India Veterinary Drugs Market by End User
10.3.6.4 Japan Veterinary Drugs Market
10.3.6.4.1 Japan Veterinary Drugs Market by Product
10.3.6.4.2 Japan Veterinary Drugs Market by Route of Administration
10.3.6.4.3 Japan Veterinary Drugs Market by End User
10.3.6.5 South Korea Veterinary Drugs Market
10.3.6.5.1 South Korea Veterinary Drugs Market by Product
10.3.6.5.2 South Korea Veterinary Drugs Market by Route of Administration
10.3.6.5.3 South Korea Veterinary Drugs Market by End User
10.3.6.6 Rest of Asia-Pacific Veterinary Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Veterinary Drugs Market by Product
10.3.6.6.2 Rest of Asia-Pacific Veterinary Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Veterinary Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Veterinary Drugs Market Overview
10.4.2 Middle East and Africa Veterinary Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Veterinary Drugs Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Veterinary Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Veterinary Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Veterinary Drugs Market
10.4.6.1.1 South Africa Veterinary Drugs Market by Product
10.4.6.1.2 South Africa Veterinary Drugs Market by Route of Administration
10.4.6.1.3 South Africa Veterinary Drugs Market by End User
10.4.6.2 Saudi Arabia Veterinary Drugs Market
10.4.6.2.1 Saudi Arabia Veterinary Drugs Market by Product
10.4.6.2.2 Saudi Arabia Veterinary Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Veterinary Drugs Market by End User
10.4.6.3 U.A.E Veterinary Drugs Market
10.4.6.3.1 U.A.E Veterinary Drugs Market by Product
10.4.6.3.2 U.A.E Veterinary Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Veterinary Drugs Market by End User
10.4.6.4 Rest of Middle East and Africa Veterinary Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Veterinary Drugs Market by Product
10.4.6.4.2 Rest of Middle East and Africa Veterinary Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Veterinary Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Veterinary Drugs Market Overview
10.5.2 South and Central America Veterinary Drugs Market Forecasts and Analysis
10.5.3 South and Central America Veterinary Drugs Market Forecasts and Analysis - By Product
10.5.4 South and Central America Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Veterinary Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Veterinary Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Veterinary Drugs Market
10.5.6.1.1 Brazil Veterinary Drugs Market by Product
10.5.6.1.2 Brazil Veterinary Drugs Market by Route of Administration
10.5.6.1.3 Brazil Veterinary Drugs Market by End User
10.5.6.2 Argentina Veterinary Drugs Market
10.5.6.2.1 Argentina Veterinary Drugs Market by Product
10.5.6.2.2 Argentina Veterinary Drugs Market by Route of Administration
10.5.6.2.3 Argentina Veterinary Drugs Market by End User
10.5.6.3 Rest of South and Central America Veterinary Drugs Market
10.5.6.3.1 Rest of South and Central America Veterinary Drugs Market by Product
10.5.6.3.2 Rest of South and Central America Veterinary Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Veterinary Drugs Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VETERINARY DRUGS MARKET, KEY COMPANY PROFILES
12.1. ZOETIS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAYER AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY AND COMPANY.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CEVA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. DECHRA PHARMACEUTICALS PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INTERVET INC. (MERCK & CO. INC.)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. VIRBAC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. VETOQUINOL S.A.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. EVONIK INDUSTRIES AG.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1.Zoetis
2.Boehringer Ingelheim International GmbH
3.Bayer AG
4.Eli Lilly and Company.
5.Ceva
6.Dechra Pharmaceuticals PLC.
7.Intervet Inc. (Merck & Co. Inc.)
8.Virbac.
9.Vetoquinol S.A.
10.Evonik Industries AG.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For